WuXi PharmaTech Forms Alliance with Shanghai Notary Public Office to Reinforce Intellectual Property Protection

    SHANGHAI, China, April 19 /PRNewswire/ -- WuXi PharmaTech
 (www.pharmatechs.com), a leading chemistry-based R&D service company located
 in Shanghai, recently agreed to collaborate with the Shanghai Notary Public
 Office, a notary agent appointed by the Chinese federal government, to use
 notarization to reinforce the protection of intellectual property and trade
 secrets of companies engaged in technology research.  The initiative bolsters
 WuXi PharmaTech's ability to safeguard the intellectual property protection to
 its customers around the world.
     (Photo:  http://www.newscom.com/cgi-bin/prnh/20040419/PHM047)
     As an official notary agency appointed by Chinese federal government, the
 Shanghai Notary Public Office will provide WuXi PharmaTech with reliable
 notarization services for contracts, agreements, certificates and other legal
 instruments, and will also provide consulting services regarding legal issues
 and regulations relating to intellectual property protection.
     The Shanghai Municipal Government takes the view that "Technological
 Innovation is the Only Way to Prosperity and Development for Shanghai City."
 The collaboration with WuXi PharmaTech aims to implement this underlying
 commercial development strategy by adding effective mechanisms to protect
 intellectual property protection in order to encourage innovation.
     At the public signing ceremony with the Shanghai Notary Office, Dr. Ge Li,
 the Chairman and CEO of WuXi PharmaTech, noted: "This agreement demonstrates
 the Chinese government's strong commitment to intellectual property
 protection. WuXi PharmaTech is proud to assist in this important initiative.
 Through this collaboration, WuXi PharmaTech continues its leadership role in
 pioneering approaches to protect our customers' intellectual property in
 China, which is a strategic priority for our company."
 
     About WuXi PharmaTech
     WuXi PharmaTech is a contract chemistry research and product development
 services company located in the WaiGaoQiao Free Trade Zone of Shanghai.
 Founded by a veteran of the US biotechnology industry, WuXi PharmaTech
 provides customers access to cost-effective world-class medicinal chemistry
 from a state-of-the-art research chemistry laboratory in Shanghai. The
 company's current customers include fourteen of the world's twenty largest
 pharmaceutical companies as well as dozens of prominent biotech companies.
 WuXi PharmaTech's laboratories are equipped with state-of-the-art
 instrumentation operated by experienced scientists to ensure high throughput
 synthesis combined with tight quality control and precise analysis. The
 company conducts custom synthesis, process research, scale up services and
 bulk synthesis of pharmaceutical intermediates.
 
      For more information, please contact:
      Shengxu Zhao
      Business Development Department
      WuXi PharmaTech Co. Ltd.
      Phone: 86-21-50460095, 50462435
      Fax: 86-21-50461087
      zhao_shengxu@pharmatechs.com
      Web Site: www.pharmatechs.com
 
 

SOURCE WuXi PharmaTech Co. Ltd.

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.